Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Canton Strategic HoldingsMEX:CNTN 14 PS Ratio is 305.00 as of Aug. 21, 2026, which is 1% above its 10-year median of 302.14. GuruFocus rates MEX:CNTN with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 930 Biotechnology companies, Canton Strategic Holdings ranks worse than 91.29% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Canton Strategic Holdings's share price is MXN36.60.
Canton Strategic Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was MXN0.12. Hence, Canton Strategic Holdings's PS Ratio for today is 305.00.
The historical rank and industry rank for Canton Strategic Holdings's PS Ratio or its related term are showing as below:
MEX:CNTN'
s PS Ratio Range Over the Past 10 Years
Min: 267.14 Med: 302.14 Max: 405.71
Current: 315.71
During the past 7 years, Canton Strategic Holdings's highest PS Ratio was 405.71. The lowest was 267.14. And the median was 302.14.
MEX:CNTN's PS Ratio is ranked worse than 91.29% of 930
companies
in the Biotechnology industry
Industry Median: 9.55
vs MEX:CNTN: 315.71
Canton Strategic Holdings (MEX:CNTN) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Canton Strategic Holdings PS Ratio Related Terms
Canton Strategic Holdings PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Canton Strategic Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Canton Strategic Holdings PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Canton Strategic Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where Canton Strategic Holdings's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Canton Strategic Holdings's Share Price of today is MXN36.60. Canton Strategic Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0.12.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Canton Strategic Holdings (MEX:CNTN) has a PS Ratio of 305.00 as of Aug. 21, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Canton Strategic Holdings and its competitors. This is near median its historical median of 302.14. Over the past decade, Canton Strategic Holdings' PS Ratio has ranged from 267.14 to 405.71. According to the industry distribution chart, Canton Strategic Holdings ranks #849 out of 930 companies in the Biotechnology industry, placing it in the top 91.3%.
Is Canton Strategic Holdings' PS Ratio too high?
Canton Strategic Holdings' current PS Ratio of 305.00 is near median its 10-year median of 302.14. Over the past 10 years, this metric has ranged from a low of 267.14 to a high of 405.71. The Biotechnology industry median PS Ratio is 9.55. Canton Strategic Holdings' value of 305.00 is 3093.7% above this industry median. Based on the distribution chart, Canton Strategic Holdings ranks #849 out of 930 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Canton Strategic Holdings has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Canton Strategic Holdings' PS Ratio compare to UNCY and ABOS?
According to the Biotechnology industry distribution chart, Canton Strategic Holdings ranks #849 out of 930 companies for PS Ratio. This places Canton Strategic Holdings in the lower half of its industry. The industry median PS Ratio is 9.55. Canton Strategic Holdings' value of 305.00 is 3093.7% above this benchmark. Historically, Canton Strategic Holdings' own PS Ratio has ranged from 267.14 to 405.71 over the past decade. While the company's 10-year median is 302.14 vs. the industry median of 9.55, Canton Strategic Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.55, based on 930 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Canton Strategic Holdings's current PS Ratio of 305.00 is 3093.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Canton Strategic Holdings and its competitors. For the Biotechnology industry, the median PS Ratio is 9.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Canton Strategic Holdings's current PS Ratio is 305.00, which is near median its own 10-year median of 302.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Canton Strategic Holdings stock overvalued right now?
Canton Strategic Holdings (MEX:CNTN) has a current PS Ratio of 305.00. The current PS Ratio is 305.00, which is near median its 10-year median of 302.14 and 3093.7% above the Biotechnology industry median of 9.55. Canton Strategic Holdings' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Canton Strategic Holdings (MEX:CNTN), the current PS Ratio is 305.00 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
14GF Score
Get the complete analysis for MEX:CNTN
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CNTN has been successfully added to your 
